United Therapeutics [UTHR] vs Zoetis [ZTS] Detailed Stock Comparison

United Therapeutics

NASDAQ

Zoetis

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: United Therapeutics wins in 15 metrics, Zoetis wins in 4 metrics, with 0 ties. United Therapeutics appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	United Therapeutics	Zoetis	Better
P/E Ratio (TTM)	11.76	25.36	United Therapeutics
Price-to-Book Ratio	1.90	13.14	United Therapeutics
Debt-to-Equity Ratio	0.00	137.01	United Therapeutics
PEG Ratio	1.23	23.24	United Therapeutics
EV/EBITDA	6.63	17.91	United Therapeutics
Profit Margin (TTM)	40.36%	27.83%	United Therapeutics
Operating Margin (TTM)	45.64%	40.20%	United Therapeutics
EBITDA Margin (TTM)	45.64%	40.20%	United Therapeutics
Return on Equity	19.30%	52.77%	Zoetis
Return on Assets (TTM)	12.96%	15.37%	Zoetis
Free Cash Flow (TTM)	$1.08B	$2.30B	Zoetis
Dividend Yield	N/A	1.11%	N/A
1-Year Return	-2.45%	-16.11%	United Therapeutics
Price-to-Sales Ratio (TTM)	4.43	6.96	United Therapeutics
Enterprise Value	$10.58B	$70.67B	Zoetis
EV/Revenue Ratio	3.44	7.53	United Therapeutics
Gross Profit Margin (TTM)	89.03%	73.62%	United Therapeutics
Revenue per Share (TTM)	$69	$21	United Therapeutics
Earnings per Share (Diluted)	$25.62	$5.81	United Therapeutics
Beta (Stock Volatility)	0.57	0.88	United Therapeutics

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

United Therapeutics vs Zoetis Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
United Therapeutics	0.34%	3.86%	6.78%	3.03%	-16.01%	-13.07%
Zoetis	1.51%	4.59%	0.82%	-3.89%	-1.51%	-5.23%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
United Therapeutics	-2.45%	39.52%	191.96%	101.19%	556.32%	795.94%
Zoetis	-16.11%	-9.09%	-2.69%	242.31%	396.97%	396.97%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

United Therapeutics (UTHR): View Full Stock Overview

Zoetis (ZTS): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: United Therapeutics vs Zoetis

Metric	UTHR	ZTS
Market Information
Market Cap i	$13.63B	$65.30B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	934,920	4,111,510
90 Day Avg. Volume i	575,800	3,459,870
Last Close	$313.13	$167.10
52 Week Range	$266.98 - $417.82	$139.70 - $200.33
% from 52W High	-25.06%	-16.59%
All-Time High	$417.82 (Nov 04, 2024)	$249.27 (Dec 27, 2021)
% from All-Time High	-25.06%	-32.96%
Growth Metrics
Quarterly Revenue Growth	0.12%	0.04%
Quarterly Earnings Growth	0.11%	0.15%
Financial Health
Profit Margin (TTM) i	0.40%	0.28%
Operating Margin (TTM) i	0.46%	0.40%
Return on Equity (TTM) i	0.19%	0.53%
Debt to Equity (MRQ) i	0.00	137.01
Cash & Liquidity
Book Value per Share (MRQ)	$158.65	$11.21
Cash per Share (MRQ)	$67.41	$3.28
Operating Cash Flow (TTM) i	$1.37B	$2.93B
Levered Free Cash Flow (TTM) i	$811.05M	$2.29B
Dividends
Last 12-Month Dividend Yield i	N/A	1.11%
Last 12-Month Dividend i	N/A	$1.86

Valuation & Enterprise Metrics Analysis: United Therapeutics vs Zoetis

Metric	UTHR	ZTS
Price Ratios
P/E Ratio (TTM) i	11.76	25.36
Forward P/E i	10.81	23.24
PEG Ratio i	1.23	23.24
Price to Sales (TTM) i	4.43	6.96
Price to Book (MRQ) i	1.90	13.14
Market Capitalization
Market Capitalization i	$13.63B	$65.30B
Enterprise Value i	$10.58B	$70.67B
Enterprise Value Metrics
Enterprise to Revenue i	3.44	7.53
Enterprise to EBITDA i	6.63	17.91
Risk & Other Metrics
Beta i	0.57	0.88
Book Value per Share (MRQ) i	$158.65	$11.21

Financial Statements Comparison: United Therapeutics vs Zoetis

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	UTHR	ZTS
Revenue/Sales i	$794.40M	$2.22B
Cost of Goods Sold i	$92.50M	$622.00M
Gross Profit i	$701.90M	$1.60B
Research & Development i	$149.00M	$157.00M
Operating Income (EBIT) i	$382.80M	$846.00M
EBITDA i	$449.40M	$991.00M
Pre-Tax Income i	$423.50M	$810.00M
Income Tax i	$101.30M	$179.00M
Net Income (Profit) i	$322.20M	$631.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	UTHR	ZTS
Cash & Equivalents i	$1.90B	$1.72B
Total Current Assets i	$3.94B	$5.88B
Total Current Liabilities i	$721.50M	$3.39B
Long-Term Debt i	N/A	$5.40B
Total Shareholders Equity i	$6.81B	$4.66B
Retained Earnings i	$7.54B	$12.38B
Property, Plant & Equipment i	$0	$6.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	UTHR	ZTS
Operating Cash Flow i	$463.80M	$567.00M
Capital Expenditures i	$-74.90M	N/A
Free Cash Flow i	$386.30M	$438.00M
Debt Repayment i	$-100.00M	N/A
Common Stock Repurchase i	$0	$-443.00M

Short Interest & Institutional Ownership Analysis

Metric	UTHR	ZTS
Shares Short i	1.57M	7.85M
Short Ratio i	3.62	2.67
Short % of Float i	0.05%	0.02%
Average Daily Volume (10 Day) i	934,920	4,111,510
Average Daily Volume (90 Day) i	575,800	3,459,870
Shares Outstanding i	44.83M	448.47M
Float Shares i	41.71M	442.37M
% Held by Insiders i	0.02%	0.00%
% Held by Institutions i	1.00%	0.98%

Dividend Analysis & Yield Comparison: United Therapeutics vs Zoetis

Metric	UTHR	ZTS
Last 12-Month Dividend i	N/A	$1.86
Last 12-Month Dividend Yield i	N/A	1.11%
3-Year Avg Annual Dividend i	N/A	$1.63
3-Year Avg Dividend Yield i	N/A	0.24%
3-Year Total Dividends i	N/A	$4.90
Ex-Dividend Date	N/A	Apr 21, 2025

United Therapeutics [UTHR] vs Zoetis [ZTS] Detailed Stock Comparison